{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:25:29Z","timestamp":1788920729986,"version":"build-2803163510"},"reference-count":55,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2022,7,1]]},"DOI":"10.1001\/jamacardio.2022.0901","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T11:36:48Z","timestamp":1652269008000},"page":"723","source":"Crossref","is-referenced-by-count":35,"title":["Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes and All-Cause Mortality"],"prefix":"10.1001","volume":"7","author":[{"given":"Aniruddh P.","family":"Patel","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Cardiovascular Disease Initiative, Broad Institute of MIT, Harvard, Cambridge, Massachusetts"},{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts"},{"name":"Cardiovascular Research Center, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline S.","family":"Dron","sequence":"additional","affiliation":[{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Cardiovascular Disease Initiative, Broad Institute of MIT, Harvard, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minxian","family":"Wang","sequence":"additional","affiliation":[{"name":"Chinese Academy of Sciences Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Pirruccello","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Cardiovascular Disease Initiative, Broad Institute of MIT, Harvard, Cambridge, Massachusetts"},{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts"},{"name":"Cardiovascular Research Center, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenney","family":"Ng","sequence":"additional","affiliation":[{"name":"Center for Computational Health, IBM Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Natarajan","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Cardiovascular Disease Initiative, Broad Institute of MIT, Harvard, Cambridge, Massachusetts"},{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts"},{"name":"Cardiovascular Research Center, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Lebo","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine, Boston, Massachusetts"},{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Division of Genetics, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"Ellinor","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Cardiovascular Disease Initiative, Broad Institute of MIT, Harvard, Cambridge, Massachusetts"},{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts"},{"name":"Cardiovascular Research Center, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna G.","family":"Aragam","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Cardiovascular Disease Initiative, Broad Institute of MIT, Harvard, Cambridge, Massachusetts"},{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts"},{"name":"Cardiovascular Research Center, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit V.","family":"Khera","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Cardiovascular Disease Initiative, Broad Institute of MIT, Harvard, Cambridge, Massachusetts"},{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts"},{"name":"Verve Therapeutics, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9","key":"hoi220017r1","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics 2020 update: a report from the American Heart Association.","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"issue":"7","key":"hoi220017r2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/gim.2013.73","article-title":"ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.","volume":"15","author":"Green","year":"2013","journal-title":"Genet Med"},{"issue":"2","key":"hoi220017r3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/gim.2016.190","article-title":"Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.","volume":"19","author":"Kalia","year":"2017","journal-title":"Genet Med"},{"issue":"8","key":"hoi220017r4","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41436-021-01172-3","article-title":"ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).","volume":"23","author":"Miller","year":"2021","journal-title":"Genet Med"},{"issue":"8","key":"hoi220017r5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015473","article-title":"Contemporary insights into the genetics of hypertrophic cardiomyopathy: toward a new era in clinical testing?","volume":"9","author":"Mazzarotto","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"20","key":"hoi220017r6","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1161\/CIRCULATIONAHA.105.550806","article-title":"Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy.","volume":"112","author":"Ahmad","year":"2005","journal-title":"Circulation"},{"issue":"25","key":"hoi220017r7","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/j.jacc.2007.06.062","article-title":"Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy.","volume":"50","author":"Monserrat","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"hoi220017r8","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1172\/JCI29042","article-title":"Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy.","volume":"117","author":"Muchir","year":"2007","journal-title":"J Clin Invest"},{"issue":"4","key":"hoi220017r9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.3959","article-title":"Association of rare pathogenic DNA variants for familial hypercholesterolemia, hereditary breast and ovarian cancer syndrome, and Lynch syndrome with disease risk in adults according to family history.","volume":"3","author":"Patel","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"9","key":"hoi220017r11","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41436-018-0039-z","article-title":"Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).","volume":"20","author":"Hershberger","year":"2018","journal-title":"Genet Med"},{"issue":"6","key":"hoi220017r12","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines and the Heart Failure Society of America.","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"hoi220017r13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jchf.2014.08.003","article-title":"Diltiazem treatment for preclinical hypertrophic cardiomyopathy mutation carriers: a pilot randomized trial to modify disease expression.","volume":"3","author":"Ho","year":"2015","journal-title":"JACC Heart Fail"},{"issue":"3","key":"hoi220017r14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ajhg.2012.07.017","article-title":"Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts.","volume":"91","author":"Bick","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"8","key":"hoi220017r15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/0002-9149(94)90337-9","article-title":"Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study.","volume":"73","author":"Maron","year":"1994","journal-title":"Am J Cardiol"},{"issue":"1","key":"hoi220017r16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/CIRCULATIONAHA.119.039573","article-title":"Genomics-first evaluation of heart disease associated with titin-truncating variants.","volume":"140","author":"Haggerty","year":"2019","journal-title":"Circulation"},{"issue":"10","key":"hoi220017r17","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.jacc.2020.01.013","article-title":"Titin-truncating variants in adults without known congestive heart failure.","volume":"75","author":"Pirruccello","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"hoi220017r18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41525-021-00211-x","article-title":"Genetic variants associated with inherited cardiovascular disorders among 13,131 asymptomatic older adults of European descent.","volume":"6","author":"Lacaze","year":"2021","journal-title":"NPJ Genom Med"},{"issue":"11","key":"hoi220017r19","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jacc.2021.07.017","article-title":"Phenotypic expression and outcomes in individuals with rare genetic variants of hypertrophic cardiomyopathy.","volume":"78","author":"de Marvao","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"hoi220017r20","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.1161\/CIR.0000000000000937","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy.","volume":"142","author":"Writing Committee Members","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"hoi220017r21","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/oxfordjournals.aje.a115184","article-title":"The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. The ARIC investigators.","volume":"129","year":"1989","journal-title":"Am J Epidemiol"},{"issue":"7726","key":"hoi220017r22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data.","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"issue":"3","key":"hoi220017r23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"issue":"7831","key":"hoi220017r24","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41586-020-2853-0","article-title":"Exome sequencing and characterization of 49,960 individuals in the UK Biobank.","volume":"586","author":"Van Hout","year":"2020","journal-title":"Nature"},{"issue":"1","key":"hoi220017r25","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1038\/s41467-018-06159-4","article-title":"Functional equivalence of genome sequencing analysis pipelines enables harmonized variant calling across human genetics projects.","volume":"9","author":"Regier","year":"2018","journal-title":"Nat Commun"},{"issue":"20","key":"hoi220017r26","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1093\/bioinformatics\/btu356","article-title":"Toward better understanding of artifacts in variant calling from high-coverage samples.","volume":"30","author":"Li","year":"2014","journal-title":"Bioinformatics"},{"issue":"5","key":"hoi220017r27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"2","key":"hoi220017r28","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1161\/CIRCHEARTFAILURE.111.963199","article-title":"Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria.","volume":"5","author":"Rosamond","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"6","key":"hoi220017r30","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1161\/CIRCULATIONAHA.120.052430","article-title":"Quantifying and understanding the higher risk of atherosclerotic cardiovascular disease among South Asian individuals: results from the UK Biobank prospective cohort study.","volume":"144","author":"Patel","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"hoi220017r35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1161\/CIRCIMAGING.113.000736","article-title":"Rationale and design of a multicenter echocardiographic study to assess the relationship between cardiac structure and function and heart failure risk in a biracial cohort of community-dwelling elderly persons: the Atherosclerosis Risk in Communities study.","volume":"7","author":"Shah","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"hoi220017r36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12968-016-0227-4","article-title":"UK Biobank\u2019s cardiovascular magnetic resonance protocol.","volume":"18","author":"Petersen","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"issue":"8","key":"hoi220017r37","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/ng1847","article-title":"Principal components analysis corrects for stratification in genome-wide association studies.","volume":"38","author":"Price","year":"2006","journal-title":"Nat Genet"},{"issue":"7809","key":"hoi220017r38","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"issue":"7616","key":"hoi220017r39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans.","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"issue":"1","key":"hoi220017r40","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensembl variant effect predictor.","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"issue":"4","key":"hoi220017r41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1001\/jamacardio.2017.5333","article-title":"Association of racial\/ethnic categories with the ability of genetic tests to detect a cause of cardiomyopathy.","volume":"3","author":"Landry","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"5","key":"hoi220017r42","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jacc.2020.06.011","article-title":"Penetrance of hypertrophic cardiomyopathy in sarcomere protein mutation carriers.","volume":"76","author":"Lorenzini","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"hoi220017r43","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/gim.2016.90","article-title":"Reassessment of mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.","volume":"19","author":"Walsh","year":"2017","journal-title":"Genet Med"},{"issue":"1","key":"hoi220017r44","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1038\/s41467-021-22876-9","article-title":"A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy.","volume":"12","author":"Huda","year":"2021","journal-title":"Nat Commun"},{"issue":"9","key":"hoi220017r45","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.118.005289","article-title":"Automated and interpretable patient ECG profiles for disease detection, tracking, and discovery.","volume":"12","author":"Tison","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"16","key":"hoi220017r46","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1161\/CIRCULATIONAHA.118.034338","article-title":"Fully automated echocardiogram interpretation in clinical practice.","volume":"138","author":"Zhang","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"hoi220017r47","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1038\/s41467-020-15823-7","article-title":"Analysis of cardiac magnetic resonance imaging in 36,000 individuals yields genetic insights into dilated cardiomyopathy.","volume":"11","author":"Pirruccello","year":"2020","journal-title":"Nat Commun"},{"key":"hoi220017r48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41746-019-0216-8","article-title":"Deep learning interpretation of echocardiograms.","volume":"3","author":"Ghorbani","year":"2020","journal-title":"NPJ Digit Med"},{"issue":"1","key":"hoi220017r49","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41588-021-00962-4","article-title":"Deep learning enables genetic analysis of the human thoracic aorta.","volume":"54","author":"Pirruccello","year":"2022","journal-title":"Nat Genet"},{"issue":"6","key":"hoi220017r50","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1161\/HYPERTENSIONAHA.121.18315","article-title":"Risk-based intensive blood pressure lowering and prevention of heart failure: a SPRINT post hoc analysis.","volume":"78","author":"Molsberry","year":"2021","journal-title":"Hypertension"},{"issue":"6","key":"hoi220017r51","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1161\/HYPERTENSIONAHA.120.14690","article-title":"Incidence and implications of atrial fibrillation\/flutter in hypertension: insights from the SPRINT trial.","volume":"75","author":"Parcha","year":"2020","journal-title":"Hypertension"},{"issue":"6","key":"hoi220017r52","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1161\/HYPERTENSIONAHA.120.14766","article-title":"Effect of intensive blood pressure lowering on the risk of atrial fibrillation.","volume":"75","author":"Soliman","year":"2020","journal-title":"Hypertension"},{"issue":"10253","key":"hoi220017r55","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"hoi220017r10","doi-asserted-by":"crossref","unstructured":"Mirshahi? UL, Colclough? K, Wright? CF, . The penetrance of age-related monogenic disease depends on ascertainment context. Preprint posted online July 1, 2021. doi:10.1101\/2021.06.28.21259641","DOI":"10.1101\/2021.06.28.21259641"},{"key":"hoi220017r29","unstructured":"dbGaP Genotypes and Phenotypes. Atherosclerosis Risk in Communities (ARIC) cohort. Accessed September 14, 2021. https:\/\/www.ncbi.nlm.nih.gov\/projects\/gap\/cgi-bin\/study.cgi?study_id=phs000280.v7.p1"},{"key":"hoi220017r31","unstructured":"Biobank. Data providers and dates of data availability. Accessed November 10, 2019. https:\/\/biobank.ndph.ox.ac.uk\/showcase\/exinfo.cgi?src=Data_providers_and_dates"},{"key":"hoi220017r32","unstructured":"National Institutes of Health. ARIC Atherosclerosis Risk in Communities study: manual 5 electrocardiography. Accessed September 22, 2021. https:\/\/sites.cscc.unc.edu\/aric\/sites\/default\/files\/public\/manuals\/Electrocardiography.2_5.pdf"},{"key":"hoi220017r33","unstructured":"GE Medical Systems. CASE, CardioSoft, version 6. Accessed September 22, 2021. https:\/\/biobank.ndph.ox.ac.uk\/ukb\/ukb\/docs\/CardiosoftFormatECG.pdf"},{"key":"hoi220017r34","unstructured":"Biobank. 12-Lead (at rest) ECG. Accessed September 22, 2021. https:\/\/biobank.ndph.ox.ac.uk\/ukb\/ukb\/docs\/12lead_ecg_explan_doc.pdf"},{"key":"hoi220017r53","unstructured":"Ho? C, Curtain? J. Breaking news in heart failure: results from VANISH and DAPA-HF. August 27, 2021. Accessed September 7, 2021. https:\/\/www.escardio.org\/Congresses-&-Events\/ESC-Congress\/Congress-news\/breaking-news-in-heart-failure-results-from-vanish-and-dapa-hf"},{"key":"hoi220017r54","unstructured":"Valsartan for Attenuating Disease Evolution in Early Sarcomeric HCM (VANISH). ClinicalTrials.gov identifier: NCT01912534. Updated January 11, 2021. Accessed September 6, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01912534"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2792048\/jamacardiology_patel_2022_oi_220017_1656698824.0704.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T12:31:50Z","timestamp":1657715510000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2792048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2022.0901","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,1]]}}}